Zydus receives final approval for Sirolimus Tablets with 180 days of marketing ... Equity Bulls Zydus Cadila has received the final approval from the USFDA to market Sirolimus Tablets 0.5 mg with 180 days of marketing exclusivity. As per IMS data in 2013, the sales of Sirolimus 0.5mg was estimated at $11.7 million and the total market for ... |
